Intense acute phase response in ischemic patients

Area of Science:

• Biochemistry
• Immunology
• Cardiology

Background:

• Coronary heart disease (CHD) involves complex physiological responses.
• Acute phase proteins (APPs) are key indicators of inflammation and tissue damage.
• Understanding APP dynamics in CHD is crucial for diagnosis and prognosis.

Purpose of the Study:

• To quantify and qualify changes in APPs (CRP, AGP, ACT) in CHD patients.
• To compare APP profiles across different CHD severities (myocardial infarction, heart failure, unstable angina).
• To investigate the relationship between APP concentrations, glycosylation, and disease progression.

Main Methods:

• Study included 74 CHD patients (myocardial infarction, unstable angina) and 12 healthy controls.
• Immunological measurements of CRP, AGP, and ACT concentrations using rocket immunoelectrophoresis.
• Glycosylation profiles of AGP and ACT determined via crossed affinity immunoelectrophoresis.
• Serial measurements taken throughout hospitalization.

Main Results:

• Significant differences in all measured parameters between patients with and without heart failure.
• Highest APP concentrations observed in heart failure and unstable angina groups, appearing earlier in heart failure.
• Maximal reactivity coefficients for AGP and ACT preceded maximal concentrations.
• Unstable angina patients exhibited rapid APP increases and altered glycosylation, suggesting a 'primed' state.

Conclusions:

• APP levels and glycosylation patterns are significantly altered in CHD, varying by disease severity.
• Unstable angina patients demonstrate a heightened and accelerated APP response to ischemic events.
• These findings highlight the role of APPs as sensitive biomarkers in CHD progression.